Levetiracetam may be an unsuitable choice for patients with PRRT2-associated self-limited infantile epilepsy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Levetiracetam may be an unsuitable choice for patients with PRRT2-associated self-limited infantile epilepsy ; volume:23 ; number:1 ; day:25 ; month:10 ; year:2023 ; pages:1-9 ; date:12.2023
BMC pediatrics ; 23, Heft 1 (25.10.2023), 1-9, 12.2023
- Creator
-
Tian, Yang
Shi, Zhen
Cai, Jiahao
Hou, Chi
Wang, Xiuying
Zhu, Haixia
Peng, Binwei
Shi, Kaili
Li, Xiaojing
Gong, Sitang
Chen, Wen-Xiong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12887-023-04212-w
- URN
-
urn:nbn:de:101:1-2024020112311330359764
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tian, Yang
- Shi, Zhen
- Cai, Jiahao
- Hou, Chi
- Wang, Xiuying
- Zhu, Haixia
- Peng, Binwei
- Shi, Kaili
- Li, Xiaojing
- Gong, Sitang
- Chen, Wen-Xiong
- SpringerLink (Online service)
Other Objects (12)
Levetiracetam Modulates EEG Microstates in Temporal Lobe Epilepsy
Different experiences of two PRRT2-associated self-limited familial infantile epilepsy
Assessment into the usage of levetiracetam in a canine epilepsy clinic
Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy
Carbamazepine, Sodium Valproate and Levetiracetam Modulate Wnt Inhibitors in Indian Women with Epilepsy
Modified hemispherectomy for infantile hemiparesis and epilepsy
Limited attention and choice
Multiple Choice Question – Pharmacotherapy of Epilepsy
Multiple Choice Question – Pharmacotherapy of Epilepsy
Determinants of quality of life in Nigerian female patients with epilepsy on carbamazepine and levetiracetam monotherapy
An Analytical Study to Correlate Serum Levels of Levetiracetam with Clinical Course in Patients with Epilepsy
Levetiracetam Modulates EEG Microstates in Temporal Lobe Epilepsy
Different experiences of two PRRT2-associated self-limited familial infantile epilepsy
Assessment into the usage of levetiracetam in a canine epilepsy clinic
Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy
Carbamazepine, Sodium Valproate and Levetiracetam Modulate Wnt Inhibitors in Indian Women with Epilepsy
Modified hemispherectomy for infantile hemiparesis and epilepsy
Limited attention and choice
Multiple Choice Question – Pharmacotherapy of Epilepsy
Multiple Choice Question – Pharmacotherapy of Epilepsy
Determinants of quality of life in Nigerian female patients with epilepsy on carbamazepine and levetiracetam monotherapy
An Analytical Study to Correlate Serum Levels of Levetiracetam with Clinical Course in Patients with Epilepsy
Levetiracetam Modulates EEG Microstates in Temporal Lobe Epilepsy
Different experiences of two PRRT2-associated self-limited familial infantile epilepsy
Assessment into the usage of levetiracetam in a canine epilepsy clinic
Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy
Carbamazepine, Sodium Valproate and Levetiracetam Modulate Wnt Inhibitors in Indian Women with Epilepsy
Modified hemispherectomy for infantile hemiparesis and epilepsy
Limited attention and choice
Multiple Choice Question – Pharmacotherapy of Epilepsy
Multiple Choice Question – Pharmacotherapy of Epilepsy
Determinants of quality of life in Nigerian female patients with epilepsy on carbamazepine and levetiracetam monotherapy